Stokes Bio sold to US-based Life Technologies
Summary
Bank of Ireland Kernel Capital Equity Fund has confirmed that it has recently sold its 37% share holding in Stokes Bio Limited, an Enterprise Ireland supported spin-out of the University of Limerick, to US-based, NASDAQ-quoted, Life Technologies.with an initial investment of €300,000 from the Bank of Ireland Kernel Capital Equity Fund, an early stage equity fund supported by Bank of Ireland, Enterprise Ireland and private investors.Since 2005 a further seven separate investments by the fund followed, committing an additional €1.6m to the company.The products arising from these technologies are used for discovery of markers for cancer, that will lead to a new approach to the diagnosis of cancer, and pathogen detection.The products arising from these technologies are used for discovery of markers for cancer, that will lead to a new approach to the diagnosis of cancer, and pathogen detection.